Similarly, ISGylation of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) mediated by prostate cancer associated transcript 6 (PCAT6) protects hnRNPA2B1 from ubiquitin-dependent degradation[38]. This evidence concerns the gene HNRNPA2B1 and cancer.